Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Fidelity Management and Research Company

Investor type Private Equity Firm


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 373
Average round size
The average size of a deal this fund participated in
Portfolio companies 293
Rounds per year 4.84
Lead investments 36
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 128
Key employees 2
Stages of investment
Late Stage Venture
Private Equity

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Software
  • Therapeutics

Fidelity Management and Research Company appeared to be the VC, which was created in 1946. The fund was located in North America if to be more exact in United States. The leading representative office of defined VC is situated in the Boston.

Considering the real fund results, this VC is 16 percentage points more often commits exit comparing to other organizations. The top amount of exits for fund were in 2018. Opposing the other organizations, this Fidelity Management and Research Company works on 12 percentage points more the average amount of lead investments. The typical startup value when the investment from Fidelity Management and Research Company is more than 1 billion dollars. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of more than 100 millions dollars.

The usual cause for the fund is to invest in rounds with 6-7 partakers. Despite the Fidelity Management and Research Company, startups are often financed by Atlas Venture, Venrock, The Column Group. The meaningful sponsors for the fund in investment in the same round are Invus, Wellington Management, Redmile Group. In the next rounds fund is usually obtained by ARCH Venture Partners, EcoR1 Capital, T. Rowe Price.

Among the most popular portfolio startups of the fund, we may highlight Lyft, Moderna Therapeutics, Magic Leap. The fund has no exact preference in some founders of portfolio startups. If startup sums 4 of the founder, the chance for it to be financed is low. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Pharmaceutical, Medical Device. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The overall number of key employees were 2.

Read more

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


$175M05 Jan 2023 Boston, Massachusetts, United States

Apogee Therapeutics

Life Science
$149M07 Dec 2022 San Francisco, California, United States

Fog Pharmaceuticals

Health Care
$178M21 Nov 2022 Cambridge, Massachusetts, United States

Astera Labs

Intelligent Systems
$150M17 Nov 2022 San Jose, California, United States

Emalex Biosciences, Inc.

$250M03 Nov 2022 Illinois, United States

Artificial Intelligence
Machine Learning
$37M26 Oct 2022 San Jose, California, United States

Local Bounti

Organic Food
$23M24 Oct 2022 -

Enliven Therapeutics

Life Science
$165M13 Oct 2022 Boulder, Colorado, United States

Wasabi Technologies

Cloud Computing
Cloud Data Services
Cloud Storage
Information Technology
$125M27 Sep 2022 Boston, Massachusetts, United States
Veterinary Emergency Group Announces Its Third Round of Funding With $100 Million in Financing Co-Led by D1 Capital Partners and Fidelity Management & Research Company LLC and Supported by Durable Capital Partners LP

– VEG announced a $100m financing round co-led by D1 Capital Partners and Fidelity Management & Research Company, and supported by Durable Capital Partners.
– This third round of financing will bring total equity raised to an estimated $150m since inception and positions VEG to continue to invest in its people by providing the best support system and work culture within the veterinary field.

Checkr Raises $250M in Series E Funding

– Checkr is a San Francisco CA-based HR technology company.
– Company raised $250m in Series E funding, valuing it at $4.6b.
– The round was led by Durable Capital, Fidelity Management & Research Company LLC and Franklin Templeton with participation from BOND Capital, Khosla Ventures, IVP, T. Rowe Price, Coatue, Accel and Y Combinator.
– The new investment will be used to expand operations and business reach.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fidelity Management and Research Company?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: